Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion
Stroke · 2024-10 · 55 (10) · 2536-2546
DOI: 10.1161/strokeaha.124.045755 ↗At a glance
Übersichtsarbeit in Stroke, 2024-10. Written by Vignan Yogendrakumar and 10 co-authors. Institution: Division of Neurology, The Ottawa Hospital and Ottawa Hospital Research Institute, University of Ottawa, Canada (V.Y.). Major MEDLINE topics: Ischemic Stroke, Thrombolytic Therapy. Cited 43 times so far (Crossref); 78 references.
Topics: Schlaganfall
Abstract (original language)
Thrombolytic therapies for acute ischemic stroke are widely available but only result in recanalization early enough, to be therapeutically useful, in 10% to 30% of cases. This large gap in treatment effectiveness could be filled by novel therapies that can increase the effectiveness of thrombus clearance without significantly increasing the risk of harm. This focused update will describe the current state of emerging adjuvant treatments for acute ischemic stroke reperfusion. We focus on new treatments that are designed to (1) target different components that make up a stroke thrombus, (2) enhance endogenous fibrinolytic systems, (3) reduce stagnant blood flow, and (4) improve recanalization of distal thrombi and postendovascular thrombectomy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Neurology, The Ottawa Hospital and Ottawa Hospital Research Institute, University of Ottawa, Canada (V.Y.).
- Department of Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Australia (V.Y., B.C.V.C.).
- Laboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium (S.V., S.F.D.M.).
- Department of Neurology and Rehabilitation Medicine, University of Cincinnati, OH (E.A.M., J.P.B.).
- Department of Clinical Neurosciences, Radiology, and Community Health Sciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Canada (M.D.H., S.B.C.).
- Department of Neurology, University of Pittsburgh, PA (R.G.N.).
ORCID profiles: Vignan Yogendrakumar, Eva A Mistry, Michael D Hill, Shelagh B Coutts, Raul G Nogueira, Thanh N Nguyen, Robert L Medcalf, Joseph P Broderick, Simon F De Meyer, Bruce C V Campbell
Cite
APA
Yogendrakumar, V., Vandelanotte, S., Mistry, E. A., Hill, M. D., Coutts, S. B., Nogueira, R. G., Nguyen, T. N., Medcalf, R. L., Broderick, J. P., De Meyer, S. F., & Campbell, B. C. V. (2024). Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion. Stroke, 55(10), 2536-2546. https://doi.org/10.1161/strokeaha.124.045755
Vancouver
Yogendrakumar V, Vandelanotte S, Mistry EA, Hill MD, Coutts SB, Nogueira RG, et al. Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion. Stroke. 2024;55(10):2536-2546. doi:10.1161/strokeaha.124.045755
BibTeX
@article{Yogendrakumar2024,
author = {Yogendrakumar, Vignan and Vandelanotte, Sarah and Mistry, Eva A and Hill, Michael D and Coutts, Shelagh B and Nogueira, Raul G and Nguyen, Thanh N and Medcalf, Robert L and Broderick, Joseph P and De Meyer, Simon F and Campbell, Bruce C V},
title = {Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion},
journal = {Stroke},
year = {2024},
volume = {55},
number = {10},
pages = {2536--2546},
doi = {10.1161/strokeaha.124.045755}
}
EUVIMED